Teachers Insurance & Annuity Association of America Lowers Stake in Medical Properties Trust, Inc. (NYSE:MPW)
Teachers Insurance & Annuity Association of America lessened its stake in Medical Properties Trust, Inc. (NYSE:MPW) by 58.7% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 141,740 shares of the real estate investment trust’s stock after selling 201,313 shares during the period. Teachers Insurance & Annuity Association of America’s holdings in Medical Properties Trust were worth $2,471,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. Cullen Frost Bankers Inc. increased its holdings in Medical Properties Trust by 70.9% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 760 shares during the period. Manchester Financial Inc. purchased a new stake in shares of Medical Properties Trust during the second quarter worth approximately $33,000. Princeton Global Asset Management LLC acquired a new stake in Medical Properties Trust in the first quarter valued at approximately $37,000. Cascade Investment Advisors Inc. acquired a new stake in Medical Properties Trust in the second quarter valued at approximately $35,000. Finally, Icon Wealth Partners LLC acquired a new stake in Medical Properties Trust in the first quarter valued at approximately $42,000. Hedge funds and other institutional investors own 71.37% of the company’s stock.
Shares of MPW traded down $0.16 during midday trading on Wednesday, reaching $18.72. 122,980 shares of the stock were exchanged, compared to its average volume of 2,753,942. The business’s 50-day moving average price is $18.22 and its 200 day moving average price is $18.15. The company has a debt-to-equity ratio of 0.99, a current ratio of 8.00 and a quick ratio of 8.00. Medical Properties Trust, Inc. has a twelve month low of $13.98 and a twelve month high of $19.26. The company has a market capitalization of $8.30 billion, a price-to-earnings ratio of 13.66, a PEG ratio of 3.68 and a beta of 0.56.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 10th. Shareholders of record on Thursday, September 12th will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, September 11th. This represents a $1.04 dividend on an annualized basis and a yield of 5.56%. This is an increase from Medical Properties Trust’s previous quarterly dividend of $0.25. Medical Properties Trust’s dividend payout ratio is presently 72.99%.
In other Medical Properties Trust news, Director G Steven Dawson bought 7,476 shares of Medical Properties Trust stock in a transaction on Thursday, August 8th. The stock was bought at an average price of $18.07 per share, with a total value of $135,091.32. Following the completion of the acquisition, the director now owns 76,302 shares in the company, valued at $1,378,777.14. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Emmett E. Mclean sold 100,000 shares of the business’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $18.37, for a total transaction of $1,837,000.00. Following the sale, the insider now owns 1,066,337 shares in the company, valued at $19,588,610.69. The disclosure for this sale can be found here. 1.18% of the stock is currently owned by corporate insiders.
A number of brokerages have commented on MPW. Barclays assumed coverage on shares of Medical Properties Trust in a research report on Tuesday, September 3rd. They issued an “overweight” rating and a $20.00 price objective on the stock. SunTrust Banks increased their target price on Medical Properties Trust from $20.00 to $21.00 and gave the company a “buy” rating in a report on Tuesday, August 27th. Zacks Investment Research cut Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Wednesday, July 17th. Stifel Nicolaus set a $21.00 price target on Medical Properties Trust and gave the stock a “buy” rating in a report on Monday, August 12th. Finally, JPMorgan Chase & Co. set a $21.00 price objective on Medical Properties Trust and gave the stock a “buy” rating in a research report on Wednesday, September 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $19.35.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Article: How Investors Use a Balance Sheet
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.